This May Excitus received a Seal of Excellence from the EU Commission in the Covid-19 call of EIC Accelerator.

The EIC Accelerator supports high-risk, high-potential small and medium-sized enterprises and innovators to help them develop and bring onto the market new innovative products, services and business models that could drive economic growth.

Our disruptive Suction Device also received recognition for being Covid-19 relevant as the EU identifies disease transmission risks in field care of patients with respiratory distress. This has enabled Excitus to receive further interest from relevant life-science investors.

Phase 1 of our product development is already fully financed by Innovation Norway and our Angel Investor who built an Air Ambulance company in Scandinavia.

Comments are closed